Capricor Therapeutics Inc
CAPR
NASDAQ
Biotechnology
$6.65
USD
+2.44 (+57.96%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $252.50M
Volume 65.7M
Peer Comparison Table
(1/4) | ||||||
|---|---|---|---|---|---|---|
PROK | Prokidney Corp | $424.02M | - | +190.5% | - | |
XFOR | X4 Pharmaceuticals Inc | $404.63M | - | -71.3% | - | |
UPB | Upstream Bio Inc | $397.81M | - | +13.2% | - | |
ENTA | Enanta Pharmaceuticals Inc | $391.45M | - | +0.7% | - | |
PALI | Palisade Bio Inc | $368.58M | - | - | - | |
RCKT | Rocket Pharmaceuticals Inc | $368.29M | - | - | - | |
LXEO | Lexeo Therapeutics Inc | $363.56M | - | - | - | |
CAPR | Capricor Therapeutics Inc | $252.50M | - | - | - |
Top Peer by Growth
Prokidney Corp
+190.5% YoY Revenue
Best 1-Year Return
Palisade Bio Inc
+165.4% Return